dockets: FDA-2026-N-5817

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id
FDA-2026-N-5817 FDA Determination That PROTAMINE SULFATE (Protamine Sulfate) Intravenous; Solution, 50 Milligrams/5 Milliliters, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness Nonrulemaking 2026-06-08T12:48:39Z 0b000064b92e3f37

Links from other tables